Tone mix
Week by week 52 weeks
Share of Alvotech Ordinary Shares's 213 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of May 25, 2026 · tone -99Alvotech founder Robert Wessman warns he may quit UK over 'anti-wealth' tax raid-116
- Week of Sep 7, 2026 · tone -50Takeda Files BPCIA Suit Against Alvotech For Vedolizumab Biosimilar-103
- Week of Mar 23, 2026 · tone -50Barclays Cuts Alvotech (NASDAQ:ALVO) Price Target to $4.00-82
- Week of Feb 16, 2026 · tone +100Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80+77
- Week of Mar 30, 2026 · tone +99Alvotech (NASDAQ:ALVO) Rating Increased to Hold at Wall Street Zen+76
- Week of Dec 15, 2025 · tone +54Teva Pharmaceutical Industries Ltd: Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea+72
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Alvotech Ordinary Shares in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | +89 |
| Last 30 sessions | 14 | +68 |
| Last 90 sessions | 34 | +57 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
3 headlines, average tone +86: 3 positive, 0 neutral and 0 negative. Showing all 3.
- www.rttnews.com · 1 outletWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial WinPositive
- www.themarketsdaily.com · 1 outletAlvotech (NASDAQ:ALVO) Upgraded to "Hold" at Wall Street ZenPositive
- www.mondaq.com · 1 outletAlvotech And Advanz Pharma Announce Submission For Proposed Eylea 8 Mg BiosimilarPositive
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Weekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win | www.rttnews.com | 1 | Positive |
| Alvotech (NASDAQ:ALVO) Upgraded to "Hold" at Wall Street Zen | www.themarketsdaily.com | 1 | Positive |
| Alvotech And Advanz Pharma Announce Submission For Proposed Eylea 8 Mg Biosimilar | www.mondaq.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.morningstar.com · 1 outletAlvotech Shares Rise After FDA Okays Simlandi Manufacturing ProcessPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Alvotech Shares Rise After FDA Okays Simlandi Manufacturing Process | www.morningstar.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 1 outletFDA Clears New Manufacturing Process For Alvotech's SIMLANDI Biosimilar; Stock UpPositive
- www.finanznachrichten.de · 1 outletAlvotech S.A.: Alvotech receives FDA approval for new SIMLANDI manufacturing process that more than doubles output per batchPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FDA Clears New Manufacturing Process For Alvotech's SIMLANDI Biosimilar; Stock Up | www.rttnews.com | 1 | Positive |
| Alvotech S.A.: Alvotech receives FDA approval for new SIMLANDI manufacturing process that more than doubles output per batch | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletFinancial Contrast: Alvotech (NASDAQ:ALVO) & Editas Medicine (NASDAQ:EDIT)Neutral
- www.themarketsdaily.com · 1 outletAlvotech (NASDAQ:ALVO) Stock Has Consensus Price Target of $8.50Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Contrast: Alvotech (NASDAQ:ALVO) & Editas Medicine (NASDAQ:EDIT) | www.themarketsdaily.com | 1 | Neutral |
| Alvotech (NASDAQ:ALVO) Stock Has Consensus Price Target of $8.50 | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletAlvotech, Advanz Pharma File First Known Biosimilar Application For Eylea 8mgPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Alvotech, Advanz Pharma File First Known Biosimilar Application For Eylea 8mg | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Alvotech Ordinary Shares, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.